Developments in CAR T treatments for adult patients

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy

ASH 2018: Expert overview of the latest in CLL, ALL and AML

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

Determining the prognosis of patients with myelodysplastic syndromes using machine learning

Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

Machine learning algorithm improves prognosis accuracy for patients with myelodysplastic syndromes

Progression-free survival milestones in primary central nervous system lymphoma

New therapies for transfusion dependent MDS patients

Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

Latest analysis of the ELIANA trial for acute lymphocytic leukaemia